Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...

Antiasthma Drugs: β2-Adrenoceptor Agonists

Antiasthma Drugs: β₂-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...

Adrenergic Agonists: Therapeutic Classification

Adrenergic Agonists: Therapeutic Classification

Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Adrenergic Agonists: Mixed-Action Agents

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Remote, bivariate prior elicitation for a Bayesian non-inferiority randomized controlled trial.

Trials·2026

Same author

AI for predicting exacerbations in KIDs with asthma (AIRE-KIDS).

NPJ digital medicine·2026

Same author

Follow-Up 18F-Fluorodeoxyglucose Positron Emission Tomography in Treated Patients With Giant Cell Arteritis: A Systematic Review and Metaanalysis.

The Journal of rheumatology·2026

Same author

Persistent Vomiting Among Children With Acute Gastroenteritis: A Secondary Analysis of a Randomized Clinical Trial.

JAMA network open·2026

Same author

Telehealth Treatments of Common Psychological Disorders: An Overview and Meta-analysis.

Journal of occupational rehabilitation·2026

Same author

Single dose IV ketamine for adolescent suicidal ideation in the emergency department: a pilot randomized trial.

BMC psychiatry·2026

Search research articles

Related Experiment Video

Updated: May 31, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Epinephrine for bronchiolitis.

Lisa Hartling¹, Liza M Bialy, Ben Vandermeer

¹Department of Pediatrics, University of Alberta, Aberhart Centre One, Room 9424, 11402 University Avenue, Edmonton, Alberta, Canada, T6G 2J3.

The Cochrane Database of Systematic Reviews

|June 17, 2011

Summary

This summary is machine-generated.

Epinephrine effectively reduces short-term hospital admissions for young children with acute viral bronchiolitis, especially within 24 hours. Combined epinephrine and steroid therapy may offer later benefits, warranting further research.

More Related Videos

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease

Published on: May 10, 2024

Related Experiment Videos

Last Updated: May 31, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease

Published on: May 10, 2024

Area of Science:

Pediatric Pulmonology
Critical Care Medicine
Evidence-Based Medicine

Background:

Bronchodilators are frequently used for acute bronchiolitis in children, but their effectiveness is not well-established.
Acute viral bronchiolitis is a common respiratory illness in infants and young children.

Purpose of the Study:

To evaluate the efficacy and safety of epinephrine in treating acute viral bronchiolitis in children under two years old.
To compare epinephrine with placebo and other bronchodilators for pediatric bronchiolitis.

Main Methods:

Systematic review and meta-analysis of randomized controlled trials (RCTs) identified through comprehensive database searches.
Inclusion criteria focused on children under two with acute viral bronchiolitis, comparing epinephrine to placebo or other interventions.
Primary outcomes included admission rates and length of stay; secondary outcomes covered clinical severity, symptoms, and adverse events.

Main Results:

Epinephrine significantly reduced Day 1 admissions for outpatients compared to placebo, but not Day 7 admissions.
Inpatients receiving epinephrine had a shorter length of stay compared to salbutamol.
Combined epinephrine and steroid therapy showed a reduced Day 7 admission rate versus placebo in one RCT; no significant adverse events were noted.

Conclusions:

Epinephrine demonstrates superiority over placebo for short-term outcomes in outpatients with acute bronchiolitis.
Evidence suggests potential benefits of combined epinephrine and steroid therapy for later outcomes, requiring further investigation.
Current evidence does not support the effectiveness of repeated or prolonged use of epinephrine or combined epinephrine and dexamethasone in inpatients.